ESR1 and breast cancer: The estrogenic properties of cadmium have been demonstrated in in vitro studies of human breast cancer cells, by binding to estrogen receptors and increasing cellular proliferation, with its effects being inhibited by antiestrogens (Garcia-Morales et al., 1994; Stoica et al., 2000).